OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NRIX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nurix Therapeutics (NRIX) Earnings Date & Reports

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRIX is expected to report earnings to rise 59.54% to -82 cents per share on October 09

Nurix Therapeutics NRIX Stock Earnings Reports

Q3'25

Est.

$-0.83

Q2'25

Beat

by $0.19

Q1'25

Beat

by $0.09

Q4'24

Missed

by $0.07

Q3'24

Est.

$-0.67

The last earnings report on July 09 showed earnings per share of -51 cents, beating the estimate of -71 cents. With 138.02K shares outstanding, the current market capitalization sits at 728.56M.

View a ticker or compare two or three

Compare

NRIX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NRIX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRIX showed earnings on July 09, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1700 Owens Street

Phone

+1 415 660-5320

Employees

284

Web

http://www.nurixtx.com